5th Annual Inflammatory Breast Cancer Conference July 9-10 in Boston

Article

We’re excited to announce the 5th International Inflammatory Breast Cancer (IBC) Conference, July 9-10, at the Long Wharf Marriott in Boston, MA. Executive Director, Ginny Mason RN, will be speaking on "IBC- A Patient's Perspective" on Saturday morning.

"The primary goal of the IBC conference is to bring together scientists and clinicians who are interested in understanding this unique disease, and to foster collaboration,” Mason said. The two-day symposium will offer discussion on recent innovations in the multidisciplinary treatment of inflammatory breast cancer and explore scientific advances in breast cancer that can be applied to the understanding of this disease.

In addition to presentations from experts in the field of breast cancer, interactive panel discussions and question and answer sessions will foster significant collaboration in the study of inflammatory breast cancer. The target audience includes medical oncologists, radiation oncologists, surgical oncologists, physician’s assistants, nurse practitioners, oncology nurses, physicians in training, and advocates."

The IBC conference follows the Breast Cancer: New Horizons, Current Controversies conference hosted by Harvard Medical School at the same location.

For more information click here.

Related Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Jessica MacIntyre, DNP, MBA, APRN, NP-C, AOCNP, in an interview with Oncology Nursing News
Andrea Wagner, M.S.N., RN, OCN, in an interview with Oncology Nursing News discussing her abstract on verbal orders for CRS.
John Rodriguez in an interview with Oncology Nursing News discussing his abstract on reducing nurse burnout
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
© 2024 MJH Life Sciences

All rights reserved.